Streetbeat News

Products Services

GTBIF

HITI

SHWZ

TCNNF

VRNOF

Wu-Tang Clan's Raekwon, Charlamagne tha God, and a South Carolina civil rights lawyer have been granted a license to expand the Hashstoria dispensary in Newark, which will feature a cannabis consumption lounge. In Florida, Trulieve Cannabis Corp., Verano Holdings Corp., and Green Thumb Industries Inc. have expanded their retail footprint. Trulieve recently donated an additional $500,000 to Florida's ballot initiative to legalize recreational marijuana. Medicine Man Technologies, operating as Schwazze, announced a cannabis store-within-a-store model in Fort Collins. High Tide Inc. launched sales of recreational cannabis products and consumption accessories at its 157th Canna Cabana branded retail cannabis location in Canada.

Portfolio Pulse from Jelena Martinovic

October 31, 2023 | 2:08 pm

MYNZ

PFE

Pfizer Inc (NYSE:PFE) reported a Q3 loss due to a 42% YoY contraction in revenues to $13.2 billion, largely due to a $5.6 billion COVID-19-related inventory write-down. However, non-Covid segments showed 10% operational growth, and the company is on track to reach its 2023 targets. Mainz Biomed NV (NASDAQ:MYNZ) reported positive interim results from its colorectal cancer screening campaign in partnership with Zöller-Kipper GmbH.

Portfolio Pulse from Upwallstreet

October 31, 2023 | 2:05 pm

AMZN

EPAM

EPAM Systems, Inc. (NYSE:EPAM) has announced a Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS) to help enterprises solve complex business challenges and scale innovation through cloud solutions, services, and strategies. The collaboration will focus on accelerating modernization, adopting cloud-native architecture, and leveraging artificial intelligence (AI) and advanced analytics. EPAM will establish a dedicated AWS Center of Excellence built on its more than 15,000 AWS experts who hold 5,000 AWS certifications.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 2:03 pm

VEON

VEON Ltd. (NASDAQ:VEON) has announced the launch of a new digital operator, OQ, in Uzbekistan. The operator will provide integrated digital experiences in entertainment and communication, targeting digital natives. The service will be available nationally across Uzbekistan, offering users the benefits of independent service selection, individual tariff formation, and fair payment commitment. Users will be able to connect to new mobile applications rapidly, using biometric identity verification technology.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:45 pm

STLA

TSLA

VGK

Stellantis CFO has announced that the company has overtaken Tesla to become the No.2 in the European EV market in Q3. This is seen as an important psychological step for the company.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:43 pm

BABA

BIDU

EIS

GLD

The ongoing Israel-Hamas conflict has entered its 25th day, with Israeli troops advancing into the Gaza Strip. Chinese tech giants Baidu Inc. and Alibaba Group Holding Ltd. have removed references to Israel from their online maps. The iShares MSCI Israel ETF had its most successful session of 2023, surging by as much as 4.2% on Monday. Gold, as tracked by the SPDR Gold Trust, was little moved, up 0.1% to $2,000/oz.

Portfolio Pulse from Piero Cingari

October 31, 2023 | 1:29 pm

XLO

Xilio Therapeutics, Inc. (NASDAQ:XLO) will host a virtual investor conference call and webcast on November 6, 2023, to review progress across its pipeline of tumor-activated molecules, including Phase 1/2 clinical data for XTX202. The data will be presented at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:22 pm

PMCB

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) is preparing for a meeting with the FDA to discuss the further development of its Cell-in-a-Box technology. The company is also evaluating potential opportunities for the use of its $74.6 million cash position. The Cell-in-a-Box technology, along with other potential delivery systems, provides a unique opportunity to treat patients with non-toxic chemotherapeutic prodrugs.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:22 pm

KTRA

Kintara Therapeutics Inc's stock has dropped by 69.2% after the company announced that their drug VAL-083 did not outperform existing treatments for glioblastoma. As a result, the company is discontinuing the development of VAL-083 and shifting focus to REM-001, a localized tumor treatment. Kintara will also explore strategic options to maximize shareholder value. Further data on VAL-083 is expected in 2024, while a study for REM-001 in cutaneous metastatic breast cancer is planned for the end of 2023.

Portfolio Pulse from Henry Khederian

October 31, 2023 | 1:21 pm

CGEN

Compugen Ltd. (NASDAQ:CGEN) will present new data on its lead pre-clinical asset COM503, a potential first-in-class anti-IL18BP antibody, at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in November 2023. The data suggests that COM503 has a leading edge in inhibiting tumor growth while avoiding peripheral toxicity associated with administration of a cytokine. The company plans to file an IND in 2024.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:20 pm